Tag: 22nd Century Group

  • 22nd Century Reports 66% Sequential Revenue Growth

    22nd Century Reports 66% Sequential Revenue Growth

    22nd Century Group reported third-quarter 2026 revenue of $4.8 million, up 66% from $2.9 million in the second quarter and 18.6% from $4 million a year earlier. Gross profit improved to $446,000 from a $300,000 loss in Q2 2026 and a $1.1 million loss in Q3 2025, while operating loss narrowed to $2.6 million from $3.3 million in the previous quarter. Net loss from continuing operations was $2.6 million, compared with $3.8 million a year earlier, and adjusted EBITDA loss narrowed to $2.2 million from $2.9 million in Q2.

    The company reported a 166% sequential increase in point-of-sale pack sales of its Pinnacle VLN and Pinnacle Pure cigarettes at its retail launch partner. During the quarter, it added approximately 150 stores in metropolitan New York and northern New Jersey, expanded its Pinnacle Pure lineup to six SKUs and secured regulatory approvals in 13 additional states. It also announced a distribution partnership with GoPuff. Cigarette revenue increased to $3.9 million from $2.3 million in Q2, while VLN cigarette revenue remained relatively unchanged at $32,000. Following the quarter, 22nd Century raised $5.8 million in net proceeds through an at-the-market stock offering and used $1.2 million to redeem Series B convertible preferred stock.

  • FDA Posts Additional Materials for 22nd Century MRTP Renewals

    FDA Posts Additional Materials for 22nd Century MRTP Renewals

    Today (Nov. 3), the U.S. Food and Drug Administration posted additional materials related to modified risk tobacco product renewal applications submitted by 22nd Century Group for VLN King and VLN Menthol King cigarettes. The FDA originally authorized the two products as MRTPs in December 2021, permitting the company to make specific reduced-exposure claims, including “95% less nicotine” and “Helps reduce your nicotine consumption.” The orders also require the company to include the statement “Helps you smoke less” when using the authorized claims.

    The FDA filed the renewal applications for scientific review on May 12. The original modified risk orders are valid for a fixed period, and renewal applications are required to continue marketing the products under MRTP authorization. The renewal materials include postmarket surveillance and study results required under the original orders. Public comments can be submitted through Regulations.gov under docket FDA-2019-N-0994. The FDA has not yet set a deadline for comments.

  • 22nd Century Tabs New Marketing VP

    22nd Century Tabs New Marketing VP

    Last week, 22nd Century Group appointed Katherine Rouse-Bailey as vice president of marketing as the company steps up efforts to expand awareness and sales of its reduced-nicotine VLN cigarette brand and Pinnacle products. Rouse-Bailey brings two decades of consumer health and brand-building experience from Johnson & Johnson, Galderma and Nestlé Health Science, and will lead initiatives aimed at increasing adult smoker trial, strengthening retail sell-through, and supporting the company’s broader commercialization strategy.

  • 22nd Century Reportedly Losing Key Customer

    22nd Century Reportedly Losing Key Customer

    According to the Winston-Salem Journal, 22nd Century Group received a 180-day termination notice from Smoker Friendly International, ending their exclusive private-label manufacturing agreement effective Jan. 1, 2027. The contract, signed in January 2025 and originally set to run for five years, covers the production of cigarettes and filtered cigars for the retailer’s network of more than 800 independently owned stores.

    The loss of the contract would represent a significant setback for 22nd Century, which derives nearly all of its revenue from manufacturing private-label traditional cigarettes and filtered cigars despite being known for its FDA-authorized very-low-nicotine (VLN) cigarettes. According to the WSJ, in the first quarter, the company’s traditional cigarette sales fell to $2.85 million from $5.01 million a year earlier, while filtered cigar sales declined to $873,000 from $1.1 million. The company employs about 40 people at its Mocksville, North Carolina, manufacturing facility.

    The contract termination comes as 22nd Century continues a financial restructuring that began in 2023, including reverse stock splits to maintain Nasdaq listing compliance and workforce reductions. While its VLN cigarettes remain the only combustible cigarettes authorized by the FDA as a modified-risk tobacco product, the company has struggled to generate meaningful sales despite expanded distribution, and the current FDA has shown less emphasis on very-low-nicotine cigarettes while authorizing additional flavored e-cigarette products.

  • FDA Files MRTP Renewal for Two 22nd Century Products

    FDA Files MRTP Renewal for Two 22nd Century Products

    Today (May 12), FDA filed two modified risk tobacco product (MRTP) renewal applications for scientific review for 22nd Century Group Inc. products VLN King and VLN Menthol King. Both products are combusted, filtered cigarettes that contain a reduced amount of nicotine compared to typical commercial cigarettes.

    The renewal follows MRTP orders first granted in 2021, which are set to expire in December 2026, requiring FDA reauthorization for continued marketing with reduced-risk claims. The agency has begun releasing redacted application materials for public access and has opened a docket for public comment, allowing stakeholders to submit data and feedback as part of the review process.

  • 22nd Century Reports $4.1M in Revenue as it Focuses on Future

    22nd Century Reports $4.1M in Revenue as it Focuses on Future

    22nd Century Group reported first-quarter 2026 revenue of $4.1 million, with a continued focus on expanding its reduced-nicotine VLN cigarette portfolio and distribution footprint. The company said it is gaining traction with adult smokers, with products now available in more than 2,000 stores across 20 states and targeting over 5,000 retail locations by the end of 2026.

    The company is positioning its proprietary low-nicotine technology as aligned with potential future FDA standards, while pursuing a broader product pipeline across cigarettes, filtered cigars and other formats. Despite ongoing net losses, 22nd Century said it is prioritizing distribution growth, regulatory engagement, and margin improvement, with plans to expand licensing opportunities and advance multiple PMTA submissions to support long-term growth.

  • 22nd Century Announced May 7 Financial Call

    22nd Century Announced May 7 Financial Call

    22nd Century Group, Inc. announced that it will host a webcast on May 7 at 8 a.m. ET to discuss its first-quarter 2026 financial results, which are scheduled to be released earlier that day. Company executives, including CEO Larry Firestone and CFO Dan Otto, will review performance, outline progress during the quarter, and provide an update on plans for the remainder of 2026.

    The webcast will be available live and archived on the company’s investor relations website, with participants encouraged to register in advance.

  • 22nd Century Expands Low-Nicotine Research with NC State

    22nd Century Expands Low-Nicotine Research with NC State

    22nd Century Group entered a testing services agreement with North Carolina State University to validate new low-nicotine tobacco varieties designed to improve yield and leaf quality while maintaining reduced nicotine levels, the company said. The research will evaluate genetic traits, crop performance, and commercial scalability as the company looks to strengthen its supply chain.

    The initiative builds on 22nd Century’s proprietary reduced-nicotine platform, which underpins its FDA-authorized VLN cigarette products. The company said the collaboration is aimed at supporting long-term production efficiency and aligning with evolving regulatory focus on nicotine reduction.

  • 22nd Century Debt-Free in Announcing 2025 Results

    22nd Century Debt-Free in Announcing 2025 Results

    22nd Century Group, Inc. reported its fourth-quarter and full-year 2025 results, highlighting strategic growth and a strengthened financial position. The company emphasized expansion of its VLN and Partner VLN product lines, increased retail distribution, and progress toward profitability. CEO Larry Firestone noted that 2025 saw a shift to higher-margin branded products, partnerships with major retailers, and the development of a tobacco harm-reduction category. The company ended 2025 debt-free with $7.1 million in cash and eliminated over $8 million in legacy debt, also receiving a $9.5 million insurance settlement from its 2022 Grass Valley facility fire.

    Financially, fourth-quarter net revenues were $3.5 million, down from $4 million in Q3, while net loss improved to $2.8 million versus $3.8 million previously. Adjusted EBITDA loss narrowed to $2.4 million. For the full year, net revenues were $17.6 million, down 28% from 2024, with a net loss of $13.1 million. Product-wise, cigarette sales increased slightly to $2.6 million in Q4, VLN product sales continued to grow with 8,800 cartons shipped, and Pinnacle VLN expanded to nearly 1,500 stores in a top-5 convenience chain.

    Looking ahead, 22nd Century plans to expand retail availability, increase consumer awareness, scale VLN distribution globally, and maintain active engagement with FDA regulators and public health stakeholders.

  • 22nd Century Group to Announce Q4, FY25 Results March 26

    22nd Century Group to Announce Q4, FY25 Results March 26

    22nd Century Group, Inc. announced it will host a webcast on March 26 at 8 a.m. ET to discuss its fourth-quarter and full-year 2025 financial results, which will be released earlier that morning. Chairman and CEO Larry Firestone and CFO Dan Otto will review performance, outline recent progress, and provide an update on the company’s 2026 plans.